"

乐虎体育|首页,小说排行榜完结版,好看的言情小说,玄幻小说排行榜完本,新寡妇村传奇,盗墓笔记,琅琊榜 海宴 小说,遮天 辰东 小说笔趣阁,懒人听书,盗墓笔记同人小说,完美世界 辰东 小说

<address id="n3xhf"></address>
<address id="n3xhf"></address>
<form id="n3xhf"><span id="n3xhf"><nobr id="n3xhf"></nobr></span></form>
<form id="n3xhf"><nobr id="n3xhf"></nobr></form>

        <address id="n3xhf"></address>
          <form id="n3xhf"></form>"
          CN | EN
          Banner

          Kexing BiopharmKexing Biopharm

          正中醫藥

           Kexing Biopharm is an innovative biopharmaceutical enterprise mainly engaged in the R&D, production and sales of recombinant protein therapeutics and microbiota agents. It focuses on pharmaceutical research in the therapeutic fields of antiviral, hematology, oncology and immunology, and degenerative diseases, and has accumulated know-how on traditional Chinese medicine and chemical pharmacy related technology in the above fields.


          At present, our main products include the recombinant protein therapeutics "Recombinant Human Erythropoietin", "Recombinant Human Interferon α1b" and "Recombinant Human Granulocyte Colony-stimulating Factor", as well as the microbiota agents "Combined Clostridium Butyricum and Bifidobacterium".


          Following the philosophy of "Precise Products, Predictable Effects, Health Protection", Kexing Biopharm  Focus on the development strategy of biological drugs, and will continue to promote in research and development, industrialization, marketing, talent and organization, and ensure the implementation of the development strategy of biological drugs.


           

          Core Products:

          SINOGEN

          Chinese genetically engineered α1 interferon

          Recombinant Human Interferon α1b for Injection (trade name: SINOGEN), included in the National Essential Medicines List and the National Reimbursement Drug List (category B), has broad-spectrum antiviral, antitumor, and immunoregulatory effects.

          Read more
          SINOGEN

          EPOSINO

          The Selection of Anti-anaemia in Multi-field

          Recombinant Human Erythropoietin Injection (CHO cell) (trade name: EPOSINO), included in the National Essential Medicines List and the National Reimbursement Drug List (category B), covers the domestic clinical market in various provinces and has been exported to more than 20 countries including Brazil, Philippines, and Indonesia.


          Read more
          EPOSINO

          White-C

          An initial choice for the prevention and treatment of neutrophilic granulocytopenia

          Recombinant Human Granulocyte Colony-stimulating Factor Injection (rhG-CSF) (trade name: WHITE-C) is an initial choice for increasing leucocytes and improving the hematopoietic function of bone marrow after radiotherapy/chemotherapy.

          Read more
           White-C

          CHANG LEKANG

          A probiotic that is explicitly approved for use by the old and the young, as well as pregnant women before and after delivery, in the package insert.

          Combined Clostridium Butyricum and Bifidobacterium Powder/Capsule, Live (CHANG LEKANG) is a combination of clostridium butyricunm and bifidobacterium infantis. Both bacterial strains are dominant in autochthonous intestinal flora and can synergistically promote the growth of each other. With proven immunoregulatory effect and a wide range of clinical applications and evidence-based support, it is a probiotic that is explicitly approved for use by the old and the young, as well as pregnant women before and after delivery, in the package insert.

          Read more
          CHANG LEKANG

          ?2017 Genzon Investment Group Co., Ltd. all rights reserved| 粵IPC備14060846號

          乐虎体育|首页

          <address id="n3xhf"></address>
          <address id="n3xhf"></address>
          <form id="n3xhf"><span id="n3xhf"><nobr id="n3xhf"></nobr></span></form>
          <form id="n3xhf"><nobr id="n3xhf"></nobr></form>

                <address id="n3xhf"></address>
                  <form id="n3xhf"></form>